/**/ document.writeln("\n\n\n\n\n \n\n\n\n\n \n \n \n\n
\n\n \n
\n \n \n \n \n
 Recent News for Unigene Laboratories Inc.\n \n\n\n\n\n
Nov 20 9:43 PM EST
\n\n\n\n
\n \n
\n \n \n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n Nov 09, 2009 4:05 PM EST
\n\n \n Unigene Announces Financial Results for Third Quarter 2009 - Business Wire\n \n \n
\n\n Nov 04, 2009 7:31 AM EST
\n\n \n Unigene to Release Third Quarter 2009 Results and Host Conference Call - Business Wire\n \n \n
\n\n Oct 20, 2009 3:14 PM EDT
\n\n \n Unigene to Host Conference Call to Discuss Phase III Oral Calcitonin Licensing Agreement with Tarsa Therapeutics - Business Wire\n \n \n
\n\n Oct 20, 2009 7:30 AM EDT
\n\n \n Unigene Licenses Phase III Oral Calcitonin Program to Tarsa Therapeutics - Business Wire\n \n \n
\n\n Sep 02, 2009 8:01 AM EDT
\n\n \n U.S. District Court Confirms Validity of Unigene's Fortical(R) Patent - Business Wire\n \n \n
\n\n May 29, 2009 10:30 AM EDT
\n\n \n Unigene Draws Down Remaining $5 Million from Non-Convertible Debt Financing - US Equity News\n \n \n
\n\n May 08, 2009 2:00 PM EDT
\n\n \n OTC Select Announces Daily Stock Watch - World Stock Wire\n \n \n
\n
\n\n");